Form 4 for JANX Janux Therapeutics, Inc.

Accepted 2024-07-22 00:00:00 ET · period of report 2024-07-19 · accession 0001415889-24-019903 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2024-07-22	2024-07-19	JANX	Hernday Natasha	Dir	A - Grant	$0.00	+7,500	7,500	New	$0
DM	2024-07-22	2024-07-19	JANX	Hernday Natasha	Dir	A - Grant	$0.00	+25.1K	16.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-07-19	A	A	5,000	$0.00	5,000	D	—	—	(F1) Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in thirty-six equal monthly installments over a three year period, subject to the Reporting Person's continuous service on each such date.
2	Common	Common Stock	2024-07-19	A	A	2,500	$0.00	7,500	D	—	—	(F2) Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date.
3	Derivative	Stock Option (Right to Buy)	2024-07-19	A	A	8,350	$0.00	8,350	D	$44.68 · — to 2034-07-18	8,350 Common Stock	(F4) The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date.
4	Derivative	Stock Option (Right to Buy)	2024-07-19	A	A	16,700	$0.00	16,700	D	$44.68 · — to 2034-07-18	16,700 Common Stock	(F3) The shares subject to the option will vest in thirty-six equal monthly installments over three years, subject to the Reporting Person's continuous service on each such date.